BEIJING : China on Tuesday urged India to step up communication to "properly resolve" the issue with the two Chinese firms which supplied the COVID-19 antibody rapid test kits, subsequently found faulty by the Indian Council of Medical Research (ICMR).
The ICMR on Monday asked states and union territories to stop using the test kits procured from the Guangzhou Wondfo Biotech and Zhuhai Livzon Diagnostics due to the "wide variations" in their performance.
India procured around five lakh rapid antibody test kits from the two Chinese firms. Asked whether China would conduct any investigation on this issue, Chinese Foreign Ministry spokesman Geng Shuang told a media briefing here that India and China are closely coordinating and cooperating